Celiprolol therapy for vascular Ehlers-Danlos syndrome.

•  
• Overview
•  
• Identity
•  
• Additional Document Info
•  
• View All
•  

Overview

authors

• Benjamin Brooke, MD, PhD

publication date

• January 1, 2010

published in

• Lancet (London, England)  Journal

has subject area

• Adrenergic beta-Agonists
• Adrenergic beta-Antagonists
• Aneurysm, Dissecting
• Aneurysm, Ruptured
• Celiprolol
• Ehlers-Danlos Syndrome
• Humans
• Signal Transduction
• Transforming Growth Factor beta
• Vascular Diseases

Identity

Digital Object Identifier (DOI)

• https://doi.org/10.1016/s0140-6736(10)61155-5

PubMed ID

• 20825985

Additional Document Info

start page

• 1443

end page

• 4

volume

• 376

issue

• 9751